Med-tech firm ALG sees strong growth in new markets

MEDICAL technology company ALG International  is targeting high growth markets after reporting a rise in annual sales.

The Liverpool company has made great strides in the US, Middle East and Australia over the past year, and is looking for more of the same in 2015.

ALG International Holdings achieved turnover of £11m in the year to the end of August, up from £10.6m in 2013.

While sales have been solid in its mature and established UK business, the rate of growth overseas was dramatic with its offices in Los Angeles and Dubai seeing year-on-year revenue increases of 54% and 48% respectively. Its Melbourne office reported 20% growth.

The family-owned company ALG owns and operates eight medical product brands covering orthotics and prosthetics, podiatry and physiotherapy and rehabilitation. These include Diaped, the leading diabetic foot brand, Podotech and Slimflex, which provide foot care specialists with a range of innovative products, and Aortha, offering the latest material technology for use within the orthotics and prosthetics sector.

ALG also operates Algeos, its global distribution brand, which currently supplies products to more than 70 countries. In the last year ALG has increased its staff headcount from 81 to 94.

Chief executive Hugh Sheridan said: “ALG has built a reputation not only as a provider of industry-leading medical products, but increasingly as a leader in innovation and technology.

“We are excited by the future potential not only in the UK but also overseas where our offices in Australia, the United States and the United Arab Emirates are seeing substantial year-on-year growth.

“ALG will continue to develop and bring to market life-changing products that not only change the way people move, but also the way they feel.”

In addition to its product brands and distribution arm, ALG also continually invests in the research and development of existing and new products.